VJHemOnc is committed to improving our service to you

COMy 2019 | Optimizing MM treatment through understanding resistance

VJHemOnc is committed to improving our service to you

Michel Delforge

Multiple myeloma (MM) cells can become resistant to certain drugs or combinations of drugs. Michel Delforge, MD, PhD, of the University of Leuven, Leuven, Belgium, explains that understanding the mechanisms of resistance in MM will allow for the optimization of drug choice. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter